Companies will provide genotype testing, actionable genomic information and custom reporting in support of the Banner Alzheimer’s Institute’s GeneMatch registry.

By Bill Siwicki October 23, 2017

Vantari Genetics, a clinical diagnostics laboratory that provides esoteric genetic testing and contract research services, and Translational Software, a health IT firm that works in the use of genomic data for clinical decision support, are partnering to provide genotype testing, actionable genomic information and custom reporting in support of the Banner Alzheimer’s Institute’s GeneMatch registry.

GeneMatch is a national program that leverages genetic testing information to recruit participants for Alzheimer’s prevention studies. “We are grateful to be part of a talented, multidisciplinary team supporting a clinical study infrastructure to help the Banner Azheimer’s Institute enroll and genotype volunteers to advance Alzheimer’s research.”

Researchers have identified a number of genes associated with Alzheimer’s disease. The most common form of the disease is called late-onset Alzheimer’s, which usually begins after age 65 and is associated with a gene called apolipoprotein E (APOE).

Read more…